Ivan Tornos News Today

A Warsaw-based nonprofit has been awarded $30 million in state funding for an initiative to attract and retain talent to an expanded orthopedic industry.

Presents Path for Compelling and Durable Topline Growth, Improved Operational Profitability and Increased Free Cash Flow Generation Details New Capital Allocation Priorities and Commitment to...

Sustainability report highlights progress in product quality and safety, environmental and greenhouse gas emissions goals, and team member engagement and development WARSAW, Ind., May 6, 2024...

Operator: Good morning, ladies and gentlemen. And welcome to the Zimmer Biomet First Quarter 2024 Earnings Conference Call.

Zimmer Biomet is kicking off the year strong with first quarter sales growth and progress with its newer technologies, according to a May 2 earnings call.

Zimmer Biomet's first-quarter results exceeded Wall Street's expectations, but the company offered no improvement in its full-year outlook.

Print-link Zimmer Biomet Announces Successful Completion of Worlds First Robotic-Assisted Shoulder Replacement Surgery with ROSA® Shoulder System Zimmer Biomet...

These 10 defensive stocks supply investors with reliable earnings, and often dividends, when markets look uncertain.

Zimmer Biomets new CEO, Ivan Tornos, earned $10.2 million in total compensation in 2023, according to a recent Securities and Exchange Commission proxy filing.

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...